Drug Profile
Monoclonal antibody AP1
Alternative Names: AP-1Latest Information Update: 18 Jul 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Genentech; Nonindustrial source; Roche
- Class Antithrombotics; Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis